Skip to main content
. Author manuscript; available in PMC: 2021 Oct 1.
Published in final edited form as: J Pharmacokinet Pharmacodyn. 2020 Jun 4;47(5):385–409. doi: 10.1007/s10928-020-09691-3

Fig. 6.

Fig. 6

Correlation of observed SC PK characteristics versus estimated SC tissue model parameters. (a) Negative association between observed bioavailability (%) and estimated CLLymCapSC (p = 6.77×10−05). (b) No significant association between observed bioavailability (%) and estimated SLymUptSC (p = 0.547). (c) No significant association between observed Tmax (day) and estimated CLLymCapSC (p = 0.217). (d) Negative correlation between observed Tmax (day) and estimated SLymUptSC (p = 0.000143).